Kathy J. Helzlsouer, M.D., M.H.S.
Associate Director, Epidemiology and Genomics Research Program
- Telephone: (240) 276-6336
- Fax: (240) 276-7920
- E-mail: email@example.com
Epidemiology and Genomics Research Program
Division of Cancer Control and Population Sciences
National Cancer Institute
National Institutes of Health
9609 Medical Center Drive, Rm. 4E302, MSC 9763
Bethesda, MD 20892
(For express delivery, use Rockville, MD 20850)
- Cancer etiology and prevention
- Clinical and translational research
- Cancer survivorship
- Women's health
University of Pittsburgh School of Medicine
- M.H.S. - Epidemiology
The Johns Hopkins University
Dr. Helzlsouer serves as Associate Director of the Epidemiology and Genomics Research Program (EGRP) and Chief Medical Officer for the National Cancer Institute's (NCI) Division of Cancer Control and Population Sciences (DCCPS). EGRP is the largest funder of cancer epidemiologic research worldwide; its focus is to develop the knowledge base of genetic and environmental determinants of cancer occurrence and outcomes in human populations.
Dr. Helzlsouer received her medical degree from the University of Pittsburgh School of Medicine and obtained a Master’s of Health Science in Epidemiology from the Johns Hopkins University School of Public Health. She is board certified in internal medicine and medical oncology. She completed her residence at the University of Virginia and medical oncology fellowship at Johns Hopkins University. She is internationally recognized for her expertise in cancer epidemiology, cancer genetic counseling, and clinical research.
Dr. Helzlsouer has published extensively in the fields of cancer epidemiology, cancer etiology and prevention, women's health, and clinical and translational research. She has more than 400 scientific publications, including articles, book chapters, and abstracts.
Prior to joining NCI, Dr. Helzlsouer was a Professor in the Department of Epidemiology at the Johns Hopkins University Bloomberg School of Public Health. Her clinical activities focused on cancer risk assessment and cancer survivorship.
See listings of articles and other publications authored by Dr. Helzlsouer in PubMed.